1. Home
  2. INTS vs TRNR Comparison

INTS vs TRNR Comparison

Compare INTS & TRNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • TRNR
  • Stock Information
  • Founded
  • INTS 2012
  • TRNR 2017
  • Country
  • INTS United States
  • TRNR United States
  • Employees
  • INTS N/A
  • TRNR N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • TRNR Consumer Electronics/Appliances
  • Sector
  • INTS Health Care
  • TRNR Technology
  • Exchange
  • INTS Nasdaq
  • TRNR Nasdaq
  • Market Cap
  • INTS 8.0M
  • TRNR 6.8M
  • IPO Year
  • INTS 2023
  • TRNR 2023
  • Fundamental
  • Price
  • INTS $0.31
  • TRNR $7.26
  • Analyst Decision
  • INTS Strong Buy
  • TRNR
  • Analyst Count
  • INTS 3
  • TRNR 0
  • Target Price
  • INTS $8.50
  • TRNR N/A
  • AVG Volume (30 Days)
  • INTS 3.1M
  • TRNR 1.1M
  • Earning Date
  • INTS 08-07-2025
  • TRNR 08-13-2025
  • Dividend Yield
  • INTS N/A
  • TRNR N/A
  • EPS Growth
  • INTS N/A
  • TRNR N/A
  • EPS
  • INTS N/A
  • TRNR N/A
  • Revenue
  • INTS N/A
  • TRNR $6,373,000.00
  • Revenue This Year
  • INTS N/A
  • TRNR $355.02
  • Revenue Next Year
  • INTS N/A
  • TRNR N/A
  • P/E Ratio
  • INTS N/A
  • TRNR N/A
  • Revenue Growth
  • INTS N/A
  • TRNR 445.63
  • 52 Week Low
  • INTS $0.26
  • TRNR $3.74
  • 52 Week High
  • INTS $5.10
  • TRNR $1,350.00
  • Technical
  • Relative Strength Index (RSI)
  • INTS 40.08
  • TRNR 53.14
  • Support Level
  • INTS $0.26
  • TRNR $3.74
  • Resistance Level
  • INTS $0.32
  • TRNR $7.08
  • Average True Range (ATR)
  • INTS 0.04
  • TRNR 0.94
  • MACD
  • INTS 0.02
  • TRNR 0.18
  • Stochastic Oscillator
  • INTS 49.20
  • TRNR 93.12

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About TRNR Interactive Strength Inc.

Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue, and personal training revenue.

Share on Social Networks: